Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy

Clinical Research in Cardiology

Volumn 100, Issue 7, 2011, Pages 603-610

  Bulut, Daniel ^a   Scheeler, Michael ^b   Niedballa, Lisa Marie ^a   Miebach, Thomas ^a   Mügge, Andreas ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cardiomyopathy; Endothelial function; Immunoadsorption; Microparticles

Indexed keywords

BISOPROLOL; CARVEDILOL; CD31 ANTIGEN; FUROSEMIDE; GLYCOPROTEIN IB ALPHA; HYDROCHLOROTHIAZIDE; LIPOCORTIN 5; METOPROLOL; RAMIPRIL; SIMVASTATIN; SPIRONOLACTONE; TORASEMIDE; VALSARTAN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGE DISTRIBUTION; AGED; ARTERIAL STIFFNESS; ARTERY TONE; ARTICLE; BLOOD SAMPLING; CD34 SELECTION; CELL FUNCTION; CLINICAL ARTICLE; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE DURATION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE BIOPSY; HUMAN; HYPEREMIA; IMMUNOADSORPTION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DILATED CARDIOMYOPATHY; MALE; MYOCARDITIS; PARTICLE SIZE; PERIPHERAL ARTERIAL TONE; REACTIVE HYPEREMIA INDEX; SEX RATIO; VIRUS GENOME;

ADULT; CARDIOMYOPATHY, DILATED; CELL COUNT; CELL-DERIVED MICROPARTICLES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOSORBENT TECHNIQUES; INFLAMMATION; MALE; MIDDLE AGED; PILOT PROJECTS; STEM CELLS;

EID: 80051785165     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0287-2     Document Type: Article

References (52)

1. Caforio AL, Mahon NJ, Tona F, McKenna WJ (2002) Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 4:411-417 (Pubitemid 36564958)
2. Maisch B, Richter A, Sandmöller A, Portig I, Pankuweit S (2005) BMBF-Heart Failure Network. Inflammatory dilated cardiomyopathy (DCMI). Herz 30:535-544 (Pubitemid 41367146)
3. Kallwellis-Opara A, Dörner A, Poller WC, Noutsias M, Kühl U, Schultheiss HP, Pauschinger M (2007) Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol 96:469-480 (Pubitemid 47012552)
4. Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Hardt S, Goeser S, Kaya Z, Katus HA, Dengler TJ (2009) Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy. J Clin Apher 24(4):141-149
5. Bulut D, Scheeler M, Wichmann T, Börgel J, Miebach T, Mügge A (2010) Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol 99:633-638
6. Dörffel WV, Wallukat G, Dörffel Y, Felix SB, Baumann G (2004) Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up. Int J Cardiol 97:529-534 (Pubitemid 39550706)
7. Yusuf S (2002) From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis. Am J Cardiol 89(2A):18A-25A
8. Grimm W, Alter P, Maisch B (2004) Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT. Herz 29:348-352 (Pubitemid 38714962)
9. Bauersachs J, Schafer A (2004) Endothelial dysfunction in heart failure: mechanisms and therapeutic approaches. Curr Vasc Pharmacol 2:115-124 (Pubitemid 38855019)
10. Blum A (2009) Heart failure-new insights. Isr Med Assoc J 11(2):105-111
11. Heitzer T, Baldus S, von Kodolitsch Y, Rudolph V, Meinertz T (2005) Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure. Arterioscler Thromb Vasc Biol 25:1174-1179 (Pubitemid 40776605)
12. de Berrazueta JR, Guerra-Ruiz A, García-Unzueta MT, Toca GM, Laso RS, de Adana MS, Martín MA, Cobo M, Llorca J (2010) Endothelial dysfunction, measured by reactive hyperaemia using strain-gauge plethysmography, is an independent predictor of adverse outcome in heart failure. Eur J Heart Fail 12:477-483
13. Bauersachs J, Bouloumié A, Fraccarollo D, Hu K, Busse R, Ertl G (1999) Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 100:292-298 (Pubitemid 29340137)
14. Nonaka-Sarukawa M, Yamamoto K, Aoki H, Nishimura Y, Tomizawa H, Ichida M, Eizawa T, Muroi K, Ikeda U, Shimada K (2007) Circulating endothelial progenitor cells in congestive heart failure. Int J Cardiol 119:344-348 (Pubitemid 46921266)
15. Bulut D, Maier K, Bulut-Streich N, Börgel J, Hanefeld C, Mügge A (2008) Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J Card Fail 14:336-340 (Pubitemid 351636235)
16. Orozco AF, Lewis DE (2010) Flow cytometric analysis of circulating microparticles in plasma. Cytom A 77:502-514
17. Horstman LL, Jy W, Jimenez JJ, Ahn YS (2004) Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 9:1118-1135 (Pubitemid 39060833)
18. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104:2649-2652 (Pubitemid 33108128)
19. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G, Heymes C, Martinez MC, Andriantsitohaina R (2008) Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 173:1210-1219
20. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS (2004) Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 286:H1910-H1915 (Pubitemid 38525481)
21. Bulut D, Chromik AM, Mügge A. Circulating microparticles induce endothelial apoptosis and dysfunction by possible transfer of caspases (submitted)
22. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841-842 (Pubitemid 26074816)
23. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, Pumper GM, Lerman LO, Lerman A (2010) Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 31:1142-1148
24. Selamet Tierney ES, Newburger JW, Gauvreau K, Geva J, Coogan E, Colan SD, de Ferranti SD (2009) Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents. J Pediatr 154:901-905
25. Khan SS, Solomon MA, McKoy JP (2005) Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytom Part B (Clin Cytom) 64B:1-8 (Pubitemid 40960406)
26. Bulut D, Albrecht N, Imöhl M, Günesdogan B, Bulut-Streich N, Börgel J et al (2007) Hormonal status modulates circulating endothelial progenitor cells. Clin Res Cardiol 96:258-263 (Pubitemid 46740074)
27. Bulut D, Tüns H, Mügge A (2009) CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease. Eur J Clin Invest 39:17-22
28. Wallukat G, Reinke P, Dörffel WV, Luther HP, Bestvater K, Felix SB, Baumann G (1996) Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int J Cardiol 54:191-195 (Pubitemid 26188306)
29. Felix SB, Staudt A, Dörffel WV, Stangl V, Merkel K, Pohl M, Döcke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35:1590-1598 (Pubitemid 30307505)
30. Felix SB, Staudt A, Landsberger M, Grosse Y, Stangl V, Spielhagen T, Wallukat G, Wernecke KD, Baumann G, Stangl K (2002) Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 39:646-652 (Pubitemid 34158161)
31. Staudt A, Schäper F, Stangl V, Plagemann A, Böhm M, Merkel K, Wallukat G, Wernecke KD, Stangl K, Baumann G, Felix SB (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103:2681-2686 (Pubitemid 32538782)
32. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, LeJemtel TH (1992) Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 19:918-925
33. Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, Yasskiy A (2005) Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 111:310-314 (Pubitemid 40165337)
34. Fischer D, Rossa S, Landmesser U, Spiekermann S, Engberding N, Hornig B, Drexler H (2005) Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 26:65-69 (Pubitemid 40221125)
35. Vallbracht KB, Schwimmbeck PL, Kühl U, Seeberg B, Schultheiss HP (2004) Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence. Circulation. 110:2938-2945 (Pubitemid 39473621)
36. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P (2006) Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol 101:545-548 (Pubitemid 44162364)
37. Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y, Fujioka D, Saito Y, Kawabata K, Sano K, Kobayashi T, Yano T, Nakamura K (2009) Kugiyama K. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 53:323-330
38. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, Harrison DG, Hornig B, Drexler H (2002) Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106:3073-3078 (Pubitemid 35440291)
39. Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C (2000) The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35:537-544 (Pubitemid 30167009)
40. Van Wijk MJ, Van Bavel E, Sturk A, Nieuwland R (2003) Microparticles in cardiovascular diseases. Cardiovasc Res 59:277-287 (Pubitemid 37272022)
41. Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G (2006) Circulating CD31+/Annexin V apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 26:112-116 (Pubitemid 43732236)
42. Nomura S, Suzuki M, Katsura K, Xie GL, Miyazaki Y, Miyake T, Kido H, Kagawa H, Fukuhara S (1995) Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 116:235-240
43. Singh N, Gemmell CH, Daly PA, Yeo EL (1995) Elevated platelet-derived microparticle levels during unstable angina. Can J Cardiol 11:1015-1021 (Pubitemid 26024866)
44. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101:841-843 (Pubitemid 30117876)
45. Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, Ahn YS (2003) Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41:211-217 (Pubitemid 36204891)
46. Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ, McGlothlin D, Grossman W, De Marco T, Yeghiazarians Y (2009) Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant 28:1081-1086
47. Daniel L, Fakhouri F, Joly D,Mouthon L, Nusbaum P, Grunfeld JP, Schifferli J, Guillevin L, Lesavre P, Halbwachs-Mecarelli L (2006) Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int 69:1416-1423
48. Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS (2006) Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity. 39:683-690 (Pubitemid 44964371)
49. Kümpers P, Erdbrügger U, Grossheim M, Meyer GP, Hiss M, Gwinner W, Haller H, Haubitz M (2008) Endothelial microparticles as a diagnostic aid in Churg-Strauss vasculitis-induced cardiomyopathy. Clin Exp Rheumatol 26:S86-S89
50. Davizon P, López JA (2009) Microparticles and thrombotic disease. Curr Opin Hematol 16:334-341
51. Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F (2009) Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med 13:454-471
52. Barry OP, Praticò D, Savani RC, FitzGerald GA (1998) Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 102:136-144 (Pubitemid 28323840)